Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Neovacs S.A.
DescriptionHeterocomplex of a vascular endothelial growth factor (VEGF) linked to a keyhole limpet hemocyanin (KLH)
Molecular Target Not applicable
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today